-+ 0.00%
-+ 0.00%
-+ 0.00%

REVIR THERAPEUTICS RECEIVES FDA RARE PEDIATRIC DISEASE DESIGNATION FOR RTX-117 IN CHARCOT-MARIE-TOOTH DISEASE

Reuters·08/26/2026 13:00:15

Please log in to view news